Xian Chen

发表

Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients.

Yan Li, G. Zheng, Yan-juan Zhu, 2017, Lung cancer.

Estimation of cell-free circulating EGFR mutation concentration predicts outcomes in NSCLC patients treated with EGFR-TKIs

Yan Li, G. Zheng, Yan-juan Zhu, 2017, Oncotarget.

Dissecting the ferroptosis-related prognostic biomarker and immune microenvironment of driver gene-negative lung cancer

Hao Ma, Yan-juan Zhu, Hai-bo Zhang, 2022, Experimental biology and medicine.

Case Report: Two Cases of Soft-Tissue Sarcomas: High TMB as a Potential Predictive Biomarker for Anlotinib Combined With Toripalimab Therapy

Ying Cheng, Yihong Liu, Yong Li, 2022, Frontiers in Immunology.

Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer

Yan-juan Zhu, Hai-bo Zhang, Yi-Hong Liu, 2017, Oncology letters.

Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy

Jeffrey R. Whiteaker, Matthew A. Wyczalkowski, Ratna R. Thangudu, 2020, Cell.

Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC.

Yan-juan Zhu, Hai-bo Zhang, Yi-Hong Liu, 2017, Oncology letters.

Specific Gene Co-variation Acts Better Than Number of Concomitant Altered Genes in Predicting EGFR-TKI Efficacy in Non-small-cell Lung Cancer.

S. Ye, Hui-hui Chen, Yan-juan Zhu, 2020, Clinical lung cancer.

Yin-Cold or Yang-Heat Syndrome Type of Traditional Chinese Medicine Was Associated with the Epidermal Growth Factor Receptor Gene Status in Non-Small Cell Lung Cancer Patients: Confirmation of a TCM Concept

Xin Qu, Yan Li, Yong Li, 2017, Evidence-based complementary and alternative medicine : eCAM.

Partial Response to Ceritinib in a Patient With Abdominal Inflammatory Myofibroblastic Tumor Carrying a TFG-ROS1 Fusion.

Hui Peng, Yan Li, Hai-bo Zhang, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

A Rare EGFR-SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib.

T. Bekaii-Saab, Xiaobing Yang, Hai-bo Zhang, 2019, The oncologist.

Retracted: Effect of Sham Acupuncture on Chronic Pain: A Bayesian Network Meta-Analysis

Hao Ma, Yang Yu, Yan-juan Zhu, 2022, Pain medicine.

Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib–Irinotecan Combo: A Case Study

Haibo Zhang, Wenjing Wang, Yong Li, 2021, OncoTargets and therapy.

Combination of Anti-EGFR and Anti-VEGF Drugs for the Treatment of Previously Treated Metastatic Colorectal Cancer: A Case Report and Literature Review

Haibo Zhang, Yong Li, Li-Rong Liu, 2021, Frontiers in Oncology.

Case report: A case of duodenal adenocarcinoma achieving significantly long survival treating with immune checkpoint inhibitors and chemotherapy without positive biomarkers

Wen-zhu Li, Yan-juan Zhu, Hai-bo Zhang, 2022, Frontiers in Immunology.

PD-1 Combined with VEGF/VEGFR2 Inhibitors for the Re-Treatment of Metastatic Nasopharyngeal Carcinoma

Xian Chen, Yan-juan Zhu, Yong Li, 2023, Journal of Biomedical Nanotechnology.

Association of mutant EGFR L858R and exon 19 concentration in circulating cell-free DNA using droplet digital PCR with response to EGFR-TKIs in NSCLC.

Yan-juan Zhu, Hai-bo Zhang, Yi-Hong Liu, 2017, Oncology letters.

Case report: Metastatic refractory undifferentiated small round-cell sarcoma successfully treated with surufatinib and camrelizumab

I. Voutsadakis, Xian Chen, Haibo Zhang, 2024, Frontiers in oncology.

Prognostic and metabolic characteristics of a novel cuproptosis-related signature in patients with hepatocellular carcinoma

Yan-juan Zhu, Hai-bo Zhang, Yong Li, 2023, Heliyon.